--- title: "John Anthony Dibella II Sells 1,000 Shares of Simulations Plus (NASDAQ:SLP) Stock" type: "News" locale: "en" url: "https://longbridge.com/en/news/283058284.md" description: "Simulations Plus, Inc. CRO John Anthony Dibella II sold 1,000 shares of the company's stock at an average price of $13.37, totaling $13,370. Following the sale, he owns 89,140 shares valued at approximately $1.19 million, reflecting a 1.11% decrease in his position. The transaction was executed under a Rule 10b5-1 trading plan and disclosed to the SEC. Simulations Plus stock recently traded at $14.12, with a market cap of $285.29 million and a P/E ratio of -4.51. Analysts have mixed ratings on the stock, with a consensus target price of $24.40." datetime: "2026-04-16T21:52:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/283058284.md) - [en](https://longbridge.com/en/news/283058284.md) - [zh-HK](https://longbridge.com/zh-HK/news/283058284.md) --- # John Anthony Dibella II Sells 1,000 Shares of Simulations Plus (NASDAQ:SLP) Stock Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) CRO John Anthony Dibella II sold 1,000 shares of the firm's stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $13.37, for a total value of $13,370.00. Following the completion of the sale, the executive directly owned 89,140 shares in the company, valued at approximately $1,191,801.80. This represents a 1.11% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Get **Simulations Plus** alerts: ## Simulations Plus Stock Performance - 52-Week Lows? No Problem for 3 Stocks With Big Upside Potential Shares of NASDAQ:SLP traded down $0.52 during midday trading on Thursday, hitting $14.12. The company's stock had a trading volume of 495,735 shares, compared to its average volume of 348,926. The stock has a market capitalization of $285.29 million, a price-to-earnings ratio of -4.51 and a beta of 1.19. The stock's 50 day simple moving average is $12.36 and its 200 day simple moving average is $15.95. Simulations Plus, Inc. has a fifty-two week low of $11.09 and a fifty-two week high of $36.45. Simulations Plus (NASDAQ:SLP - Get Free Report) last released its earnings results on Thursday, April 9th. The technology company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.08. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. The business had revenue of $24.29 million during the quarter, compared to analysts' expectations of $21.66 million. As a group, analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current year. ## Institutional Inflows and Outflows - Simulations Plus Stock Drops 15% Despite EPS Beat A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. bought a new position in shares of Simulations Plus in the second quarter valued at approximately $25,000. Quarry LP bought a new position in shares of Simulations Plus in the third quarter valued at approximately $28,000. CWM LLC raised its stake in shares of Simulations Plus by 3,729.1% in the third quarter. CWM LLC now owns 2,106 shares of the technology company's stock valued at $32,000 after acquiring an additional 2,051 shares during the last quarter. Farther Finance Advisors LLC bought a new position in shares of Simulations Plus in the third quarter valued at approximately $40,000. Finally, Caitong International Asset Management Co. Ltd raised its stake in shares of Simulations Plus by 343.0% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,983 shares of the technology company's stock valued at $73,000 after acquiring an additional 3,084 shares during the last quarter. Institutional investors own 78.08% of the company's stock. ## Analysts Set New Price Targets Several research firms recently weighed in on SLP. TD Cowen reduced their target price on shares of Simulations Plus from $19.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 10th. BTIG Research cut shares of Simulations Plus from a "buy" rating to a "neutral" rating in a research note on Thursday, December 18th. Citigroup reiterated a "market perform" rating on shares of Simulations Plus in a research note on Tuesday, January 6th. Wall Street Zen cut shares of Simulations Plus from a "buy" rating to a "hold" rating in a research note on Saturday, April 4th. Finally, Zacks Research cut shares of Simulations Plus from a "strong-buy" rating to a "hold" rating in a research note on Monday, February 2nd. Three investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $24.40. - Simulations Plus: A Health Care Stock with Healthy Growth Prospects **Get Our Latest Research Report on Simulations Plus** ## Simulations Plus Company Profile (Get Free Report) Simulations Plus, Inc NASDAQ: SLP specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company's flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics. ## Featured Stories - Five stocks we like better than Simulations Plus _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Simulations Plus Right Now? Before you consider Simulations Plus, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list. While Simulations Plus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [SLP.US](https://longbridge.com/en/quote/SLP.US.md) ## Related News & Research - [Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products | SLP Stock News](https://longbridge.com/en/news/283494231.md) - [Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling | SLP Stock News](https://longbridge.com/en/news/280624523.md) - [SEA (NYSE:SE) Insider Jingye Chen Sells 800 Shares](https://longbridge.com/en/news/287209351.md) - [Insider Selling: Newegg Commerce (NASDAQ:NEGG) Director Sells 703 Shares of Stock](https://longbridge.com/en/news/287123213.md) - [Gas prices: Rise to new national average record high price for 2026](https://longbridge.com/en/news/287214404.md)